|Articles|January 20, 2016

Mayo Clinic Uses Robots Against C. difficile

Mayo Clinic has added robots in its fight against Clostridium difficile (C. diff) bacteria.

In the U.S., C. diff is one of the most common infections patients can get while receiving care at a healthcare facility. C. diff can cause a variety of symptoms, including potentially deadly diarrhea. A recent national report shows some progress in reducing C. diff infections; however, more work remains.

“C. diff is extremely distressing for our patients,” says Priya Sampathkumar, MD, chair of Mayo Clinic’s infection control committee on Mayo Clinic’s Rochester campus. “It can be debilitating, decrease quality of life and can even result in death.”

Preventing C. diff can be of enormous benefit to patients. But, C. diff spores are resistant to routine hospital disinfectants and require extra cleaning measures. That’s where the robots come in. These stationary devices emit pulses of ultraviolet (UV) light that kill C. diff spores on exposed surfaces.

Mayo piloted the devices in October 2014 as part of a quality improvement project with the Joint Commission Center for Transforming Healthcare, the Centers for Disease Control and Prevention, and five healthcare systems nationwide. During the six-month pilot, Mayo saw a 30 percent decrease in C. diff infections in the group of units that received the robot cleaning compared with the group that did not.

The robots supplement normal cleaning practices, says Larry Nation, director of environmental Ssrvices at Mayo Clinic. The devices go through three cycles in different parts of the patient room and add 25 minutes to the cleaning process.

“It’s worth it, because the average increased length of stays for a person with C. diff is three days,” Sampathkumar says. “If we prevent C. diff infections, we gain that time back.”

Mayo acquired 10 more robots this past fall. After training, employees started using them in early January.

Source: Mayo Clinic


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.